Cardiology (all articles)
Ambulatory management of pulmonary embolism: A comparison of two risk-stratification scores
2 Feb, 2021 | 01:11h | UTC
Resumption of cardiac activity after withdrawal of life-sustaining measures
2 Feb, 2021 | 01:09h | UTCResumption of Cardiac Activity after Withdrawal of Life-Sustaining Measures – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: When is ‘dead’ really dead? What happens after a person ‘flatlines’ – The Conversation
Leading cardiovascular organizations call for urgent action to reduce air pollution
29 Jan, 2021 | 01:36h | UTCPress release: Leading cardiovascular organizations call for urgent action to reduce air pollution – American College of Cardiology
Randomized trial: Continuous postoperative pericardial flushing reduces postoperative bleeding after coronary artery bypass grafting
29 Jan, 2021 | 01:28h | UTC
Patients with heart failure hospitalized with COVID-19 are at high risk for complications, with nearly 1 in 4 dying during hospitalization
29 Jan, 2021 | 01:46h | UTC
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
28 Jan, 2021 | 01:23h | UTC
AHA Statement: Psychological health, well-being, and the mind-heart-body connection
27 Jan, 2021 | 01:11h | UTCNews release: Mental health is important to overall health, and heart disease prevention and treatment – American Heart Association
Commentary: The head is connected to the heart – and can influence health – American Heart Association
Meta-analysis: Minimally invasive surgery versus transcatheter aortic valve replacement
27 Jan, 2021 | 01:00h | UTCCommentary: TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis – TCTMD
Commentary on Twitter
Comprehensive systematic review and meta-analysis of miniAVR vs #TAVR. Important in the context of 'lifetime management of valves'. Thank you for the opportunity. @Shoukmed @ahmedsayed8991 @BrighamSurgery @BrighamThoracic CC:@TSRA_official @STS_CTsurgery @AATSED @ThoracicsCanada https://t.co/T1XDrebl8U pic.twitter.com/5E5eOLherA
— Sameer Hirji (@Hirji1987) January 21, 2021
Vitamin D, calcium, other vitamins, and supplements do not prevent cardiovascular diseases
27 Jan, 2021 | 01:08h | UTCVitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD – TCTMD
Original study 1: Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health: JACC Focus Seminar – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Original study 2: Vitamin D, Calcium Supplements, and Implications for Cardiovascular Health: JACC Focus Seminar – Journal of the American College of Cardiology (link to abstract – $ for full-text)
RCT: In a population with a high prevalence of Rheumatic Heart Disease, screening schoolchildren with echocardiography can enable timely initiation of secondary antibiotic prophylaxis
27 Jan, 2021 | 01:05h | UTCCommentaries: Echo Screening for Rheumatic Heart Disease in Kids Gets a Boost – TCTMD
Editorial: Screening for Rheumatic Heart Disease—Quo Vadis?
Author interview: Systematic Echocardiographic Screening for Rheumatic Heart Disease in Nepalese Schoolchildren – JAMA
Commentary on Twitter
RHD accounts for the highest number of deaths due to #VHD worldwide. Cluster RCT in Nepal indicates effectiveness of early detection of clinically silent #RHD by echocardiographic screening of schoolchildren and timely initiation of secondary prophylaxis https://t.co/gCCt4LzV7X
— JAMA Cardiology (@JAMACardio) January 20, 2021
https://twitter.com/ThomPilgrim/status/1352028977519583235
Position Paper: Composition, structure, and function of heart teams
27 Jan, 2021 | 00:57h | UTC
Randomized trial: Remote, online support for blood pressure management at home is effective and low-cost
26 Jan, 2021 | 00:46h | UTC
Commentary on Twitter
NEW #BMJresearch has found that a digital intervention for the management of hypertension by using self-monitored blood pressure led to better control of systolic blood pressure after one year than usual care, with low incremental costs @RichardJMcManus https://t.co/XiNCzE0t6C
— The BMJ (@bmj_latest) January 23, 2021
Review: Ambulatory blood pressure monitoring to diagnose and manage hypertension
25 Jan, 2021 | 01:24h | UTCAmbulatory Blood Pressure Monitoring to Diagnose and Manage Hypertension – Hypertension
Machine Learning and the Future of Cardiovascular Care: JACC State-of-the-Art Review
25 Jan, 2021 | 01:08h | UTC
Commentary on Twitter
Our state-of-the-art review on Machine Learning and the Future of Cardiovascular care in @JACCJournals: "Cardiologists must shape how #ML is used in cardiovascular practice" with dr. Arnaout @UCSF (@scrippsresearch @ScrippsRTI #ai) https://t.co/dZYS6QyW12 pic.twitter.com/fLo2UhqocE
— Giorgio Quer (@GiorgioQuer) January 19, 2021
Study: Compression garment reduces orthostatic tachycardia and symptoms in patients with postural orthostatic tachycardia syndrome
25 Jan, 2021 | 01:10h | UTCCompression Garment Reduces Orthostatic Tachycardia and Symptoms in Patients With Postural Orthostatic Tachycardia Syndrome – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Reporting incidental coronary, aortic valve and cardiac calcification on non-gated thoracic computed tomography, a consensus statement from the BSCI/BSCCT and BSTI
25 Jan, 2021 | 01:02h | UTC
Meta-analysis: Colchicine reduces new cardiovascular events in patients with coronary artery disease
22 Jan, 2021 | 08:23h | UTCMeta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease – The American Journal of Cardiology (link to abstract – $ for full-text)
Related randomized trials: Colchicine in patients with chronic coronary disease (study and commentaries) AND Low-Dose Colchicine Improves Outcomes after Myocardial Infarction (study and commentaries) AND Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) (study and commentary)
Commentary on Twitter
Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease https://t.co/EbMATgpXn4
🔽Major adverse CV events 35%
🔽Risk of MI 27%
🔽Coronary revasc 39%
🔽Stroke 53% (0.47, CI 0.28-0.81)
🔴No impact on CV mortality@mencardio #colchicine— Lempira Guevara Matheus (@Lguevaramath) October 31, 2020
Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance
22 Jan, 2021 | 08:13h | UTC
Commentary on Twitter
Superhuman AI measures #HCM wall thickness better than all tested international experts. https://t.co/zjjVaFSGoo Congratulations Rhodri and team. @LancetDigitalH #EACVI#AI #WHYCMR @SCMRorg @UCL @NHSBartsHealth @dr_manisty @JoaoLCavalcante @DesaiMilindY @s_e_petersen @chiarabd pic.twitter.com/hw9R17OYHP
— James moon (@JccmoonMoon) December 4, 2020
Meta-analysis: Prevalence of postural hypotension in primary, community and institutional care
22 Jan, 2021 | 08:09h | UTC
Meta-Analysis: Low-intensity warfarin may be an option for patients under 65 years of age with non-valvular atrial fibrillation
21 Jan, 2021 | 00:57h | UTCMeta-Analysis Evaluating the Efficacy and Safety of Low-Intensity Warfarin for Patients >65 Years of Age With Non-Valvular Atrial Fibrillation – The American Journal of Cardiology (link to abstract – $ for full-text)
Randomized trial: No benefit from discontinuing ACE Inhibitors and ARBs in patients admitted with COVID-19
20 Jan, 2021 | 01:55h | UTCCommentary: Discontinuing vs. Continuing ACEIs, ARBs in Patients Admitted With COVID-19 – American College of Cardiology
Related study (study and commentary): Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19
After return of spontaneous circulation in patients with out-of-hospital cardiac arrest, too early ECG acquisition (7 minutes or less) is associated with false-positive findings for STEMI
19 Jan, 2021 | 01:44h | UTCCommentary: Delaying Electrocardiography in Cardiac Arrest: A Pause for the Cause – JAMA Network Open
Meta-Analysis: After transcatheter aortic valve implantation, Aspirin alone is a better choice than dual antiplatelet therapy
19 Jan, 2021 | 01:34h | UTCMeta-Analysis Comparing the Safety and Efficacy of Single vs. Dual Antiplatelet Therapy in Post Transcatheter Aortic Valve Implantation Patients. – American Journal of Cardiology (link to abstract – $ for full-text)
Returning to physical activity after Covid-19
17 Jan, 2021 | 22:19h | UTCReturning to physical activity after covid-19 – The BMJ
Commentary: Returning to physical activity after a Covid-19 infection – Medical Centre
Commentaries on Twitter
"Returning to #PhysicalActivity after #COVIDー19 should be gradual, individualised, and based on subjective tolerance of the activity.".#exercise #rehab
⛹️♀️🏃⚽🎾🏌️🏋️♂️🏊♀️🚴♂️🤸♀️🏸🤼
HT- @bmj_latesthttps://t.co/GnqwCBkZRN pic.twitter.com/k4nsDI6ApU
— Christopher Tuckett MCSP (@HealthPhysio) January 15, 2021
Professional experience suggests that after mild suspected covid-19 a proportion of people experience a prolonged recovery. What are the risks of physical activity after covid-19 and how to know if a patient can safely return to physical exercise?https://t.co/19Cfi4p5Ck
— The BMJ (@bmj_latest) January 11, 2021
Contradicting early research, 2 new MRI studies show lower degrees of myocarditis in athletes recovered from COVID-19
17 Jan, 2021 | 22:14h | UTCStudy 1: Evaluation for Myocarditis in Competitive Student Athletes Recovering From Coronavirus Disease 2019 With Cardiac Magnetic Resonance Imaging – JAMA Cardiology AND Commentaries: Screening Athletes for Myocarditis With Cardiac Magnetic Resonance Imaging After COVID-19 Infection—Lessons From an English Philosopher – JAMA Cardiology AND Low Prevalence of Myocarditis in Athletes Recovered from COVID-19 – docwire News
Study 2: Cardiac MRI Shows Lower Degrees of Myocarditis in Athletes Recovered From COVID-19 – Circulation AND Commentaries: Cardiac MRI shows lower degrees of myocarditis in athletes recovered from COVID-19 – Vanderbilt University Medical Center AND Heart damage less common among athletes who recover from COVID-19 than previously believed, cardiologists find – Cardiovascular Business